Difference between revisions of "Parkin"
m |
|||
| Line 2: | Line 2: | ||
! {{infobox header}}| '''{{PAGENAME}}''' | ! {{infobox header}}| '''{{PAGENAME}}''' | ||
|- | |- | ||
| − | | align="center" colspan="2" bgcolor="#ffffff" | [[Image: | + | | align="center" colspan="2" bgcolor="#ffffff" | [[Image:Parkin.JPG|200px|{{PAGENAME}}]] |
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
| Line 26: | Line 26: | ||
|- | |- | ||
| Reactive lysines | | Reactive lysines | ||
| − | | [[ | + | | [[TG2 reactive residues (Parkin)|K49]] |
|- | |- | ||
| Substrate sequence | | Substrate sequence | ||
Revision as of 11:22, 31 August 2007
| Template:Infobox header| Parkin | |
|---|---|
| |
| Substrate peptide name | Parkin |
| Synonyms | Ubiquitin E3 ligase PRKN |
| Determination type | In vitro |
| Source | Homo sapiens |
| Subcellular localization | Cytosol |
| Swissprot ID | O60260 |
| Reactive glutamines | - |
| Reactive lysines | K49 |
| Substrate sequence | VIFAGKELRND |
| Structure | 1IYF |
| Surface accessibility | ASAView pdf |
| Disorder prediction | IUPred |
| Reference | PMID:15132984 |
| Notes | |
| Template:Infobox header | | |
